Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones

Figure 3

Crystal structure of PPARγ (PDB: 2PRG entry), cocrystalized with rosiglitazone (ligand) and steroid receptor coactivator 1 (SRC-1, coactivator). Figure constructed using Visual Molecular Dynamics (VMD) software.